• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 标志物在甲状腺乳头状癌中的研究。

Micro-RNAs signatures in papillary thyroid carcinoma.

机构信息

Dept of Otorhinolaryngology, Head and Neck Surgery, Medical School, University of Patras, Greece.

出版信息

J BUON. 2020 Sep-Oct;25(5):2144-2146.

PMID:33277828
Abstract

Among biomarkers that should be useful for a molecular discrimination of patients regarding treatment strategies and prognosis in solid malignancies, novel micro-RNAs (miRs) are under investigation. Quite recently, miRs are considered very promising and significant genetic markers for categorizing patients by their molecular characteristics, as well as extending their complicated genetic signatures. miRs are short, non-coding RNAs consisting of 20-25 nucleotides located at intra- or inter-gene regions. Functional miRs mediate a positive regulation of posttranscriptional gene silencing. Their deregulation in cancer cells due to genetic (e.g., mutations, translocations), epigenetic (e.g., DNA hyper-methylation of tumor suppressor genes, extensive genomic DNA hypo-methylation, aberrant histone modification patterns) and transcriptional alterations lead to a loss of miRs-mediated repression of target mRNA. Interestingly, a biphasic role of miRs in cancers of different histogenetic origin has been confirmed. In some of them, their upregulation is correlated with an increased oncogenic activity, whereas in others, the same miR type acts as a suppressor agent. Thyroid carcinoma comprises different histological subtypes, such as papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), anaplastic thyroid cancer (ATC), and medullary thyroid carcinoma. In the current molecular review, we explored the role of a specific fraction of miRs in PTC subtype by categorizing them according to their up- or down-regulation status.

摘要

在用于实体恶性肿瘤患者治疗策略和预后的分子鉴别中,新型微小 RNA(miRs)是正在研究的生物标志物。最近,miRs 被认为是非常有前途和重要的遗传标志物,可以根据患者的分子特征对其进行分类,扩展其复杂的遗传特征。miRs 是由 20-25 个核苷酸组成的短非编码 RNA,位于基因内或基因间区域。功能性 miRs 介导转录后基因沉默的正向调节。由于遗传(例如突变、易位)、表观遗传(例如肿瘤抑制基因的 DNA 超甲基化、广泛的基因组 DNA 低甲基化、异常组蛋白修饰模式)和转录改变,癌细胞中它们的失调导致 miR 介导的靶 mRNA 抑制丧失。有趣的是,miRs 在不同组织发生来源的癌症中的双相作用已得到证实。在其中一些癌症中,miRs 的上调与致癌活性的增加相关,而在另一些癌症中,相同的 miR 类型则作为抑制剂。甲状腺癌包括不同的组织学亚型,如甲状腺乳头状癌(PTC)、滤泡状甲状腺癌(FTC)、间变性甲状腺癌(ATC)和甲状腺髓样癌。在当前的分子综述中,我们通过根据其上调或下调状态对 PTC 亚型的特定 miR 进行分类,探讨了它们的作用。

相似文献

1
Micro-RNAs signatures in papillary thyroid carcinoma.微小 RNA 标志物在甲状腺乳头状癌中的研究。
J BUON. 2020 Sep-Oct;25(5):2144-2146.
2
Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).miR-369-3p 通过下调 TSPAN13 抑制甲状腺乳头状癌(PTC)细胞增殖。
Bosn J Basic Med Sci. 2019 May 20;19(2):146-154. doi: 10.17305/bjbms.2018.2865.
3
MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer.微小RNA-146b:一种用于人甲状腺乳头状癌的新型生物标志物和治疗靶点。
Int J Mol Sci. 2017 Mar 15;18(3):636. doi: 10.3390/ijms18030636.
4
Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma.DNMT3A 改变在中东地区甲状腺滤泡状癌中的预后意义。
Eur J Cancer. 2019 Aug;117:133-144. doi: 10.1016/j.ejca.2019.05.025. Epub 2019 Jul 4.
5
MiR-137 acts as a tumor suppressor in papillary thyroid carcinoma by targeting CXCL12.微小RNA - 137通过靶向趋化因子配体12在甲状腺乳头状癌中发挥肿瘤抑制作用。
Oncol Rep. 2016 Apr;35(4):2151-8. doi: 10.3892/or.2016.4604. Epub 2016 Feb 1.
6
microRNA-599 promotes apoptosis and represses proliferation and epithelial-mesenchymal transition of papillary thyroid carcinoma cells via downregulation of Hey2-depentent Notch signaling pathway.miRNA-599 通过下调 Hey2 依赖性 Notch 信号通路促进甲状腺乳头状癌细胞凋亡,抑制增殖和上皮间质转化。
J Cell Physiol. 2020 Mar;235(3):2492-2505. doi: 10.1002/jcp.29154. Epub 2019 Sep 29.
7
Circulating ctDNA methylation quantification of two DNA methyl transferases in papillary thyroid carcinoma.甲状腺乳头状癌中两种DNA甲基转移酶的循环游离DNA甲基化定量分析
J Cell Biochem. 2019 Oct;120(10):17422-17437. doi: 10.1002/jcb.29007. Epub 2019 May 24.
8
microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.microRNA-539 通过靶向分泌白细胞蛋白酶抑制剂在甲状腺乳头状癌中作为肿瘤抑制因子通过转化生长因子β1/Smads 信号通路发挥作用。
J Cell Biochem. 2019 Jun;120(6):10830-10846. doi: 10.1002/jcb.28374. Epub 2019 Jan 31.
9
STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway.STAT3 诱导的长链非编码 RNA ABHD11-AS1 的上调通过调节 miR-1301-3p/STAT3 轴和 PI3K/AKT 信号通路促进甲状腺乳头状癌的肿瘤进展。
Cell Prolif. 2019 Mar;52(2):e12569. doi: 10.1111/cpr.12569. Epub 2019 Jan 18.
10
Long noncoding RNA LINC00313 modulates papillary thyroid cancer tumorigenesis via sponging miR-4429.长链非编码 RNA LINC00313 通过海绵吸附 miR-4429 调节甲状腺乳头状癌肿瘤发生。
Neoplasma. 2018 Nov 15;65(6):933-942. doi: 10.4149/neo_2018_180219N125. Epub 2018 Jun 17.

引用本文的文献

1
Diagnosis and Evaluation of Aggressiveness Using Circulating Plasma miRNAs in Papillary Thyroid Microcarcinoma.利用循环血浆微小RNA诊断和评估甲状腺微小乳头状癌的侵袭性
Cancers (Basel). 2025 Jun 21;17(13):2079. doi: 10.3390/cancers17132079.
2
miR-135b: A key role in cancer biology and therapeutic targets.微小RNA-135b:在癌症生物学及治疗靶点中起关键作用
Noncoding RNA Res. 2025 Feb 20;12:67-80. doi: 10.1016/j.ncrna.2025.02.005. eCollection 2025 Jun.
3
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells.
miR-31-5p 的表达影响甲状腺乳头状癌细胞的生长、迁移和侵袭能力。
Endocrine. 2023 Mar;79(3):517-526. doi: 10.1007/s12020-022-03267-6. Epub 2022 Dec 7.
4
TREM2 Is a Prognostic Biomarker and Correlated with an Immunosuppressive Microenvironment in Thyroid Cancer.TREM2 是甲状腺癌的预后生物标志物,并与免疫抑制微环境相关。
Dis Markers. 2022 Nov 16;2022:1807386. doi: 10.1155/2022/1807386. eCollection 2022.
5
Aberrant kinesin family member 2A signifies tumor size and invasion, and may help predict prognosis of patients with papillary thyroid carcinoma.异常驱动蛋白家族成员2A表明肿瘤大小和侵袭情况,可能有助于预测甲状腺乳头状癌患者的预后。
Oncol Lett. 2022 Jun 14;24(2):256. doi: 10.3892/ol.2022.13376. eCollection 2022 Aug.
6
Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.口腔鳞状细胞癌与 2 型糖尿病的遗传交叉对话:免疫的潜在作用。
Dis Markers. 2022 May 19;2022:6389906. doi: 10.1155/2022/6389906. eCollection 2022.
7
MiR-205-5p/GGCT Attenuates Growth and Metastasis of Papillary Thyroid Cancer by Regulating CD44.miR-205-5p/GGCT 通过调控 CD44 抑制甲状腺乳头状癌细胞的生长和转移
Endocrinology. 2022 Apr 1;163(4). doi: 10.1210/endocr/bqac022.